Journal article

Retinal microvascular changes and subsequent vascular events after ischemic stroke

DA De Silva, JJF Manzano, EY Liu, F-P Woon, W-X Wong, H-M Chang, C Chen, RI Lindley, JJ Wang, P Mitchell, T-Y Wong, M-C Wong

Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2011

Grants

Awarded by Australian National Health and Medical Research Council (NHMRC)


Awarded by Singapore National Medical Research Council


Funding Acknowledgements

Study funding: Supported by grants from the Australian National Health and Medical Research Council (NHMRC 352337) and Singapore National Medical Research Council (NMRC 2004/073, NMRC/0914/2004, and NMRC/0914/S2).Dr. De Silva, Dr. Manzano, E.Y. Liu, F.-P. Woon, and W.-X. Wong report no disclosures. Dr. Chang receives research support from Boehringer Ingelheim, SERVIER, Singapore BMRC, Singapore NMRC, and University of Nottingham. Dr. Chen serves on scientific advisory boards for Baxter International Inc., Allergan, Inc., and Pfizer Inc; has received funding for travel from Moleac Pte Ltd.; serves on the editorial boards of Stroke, the Journal of Neurology, Neurosurgery and Psychiatry, and the International Journal of Stroke; serves as a consultant for BrainsGate; and receives research support from GlaxoSmithKline, Merck Serono, Wyeth, Eisai Inc., and the National Medical Research Council of Singapore. Dr. Lindley receives research support from the National Health and Medical Research Council of Australia, the NSW Department of Health, and the Moran Foundation for Older Australians (funds University salary). Dr. Wang serves on the editorial boards of Clinical & Experimental Ophthalmology and the Journal of Ophthalmology; receives publishing royalties for Retinal Degenerations, Biology, Diagnostics, and Therapeutics (Humana Press, 2007); and receives research support from NHMRC, the Heart Foundation, and the Health Assistance Foundation. Dr. Mitchell serves on scientific advisory boards for Novartis, Allergan, Inc., Bayer Schering Pharma, and Pfizer Inc; has received funding for travel and speaker honoraria from Novartis, Bayer Schering Pharma, Allergan, Inc., and Abbott; serves on the editorial boards of Eye and the British Journal of Ophthalmology; and receives research support from the Australian National Health and Medical Research Council. Dr. T.-Y. Wong serves on scientific advisory boards and as a consultant for Pfizer Inc, Novartis, Bayer Schering Pharma, and Allergan, Inc.; serves as Executive Editor for the American Journal of Ophthalmology and on editorial advisory boards for Investigative Ophthalmology and Visual Sciences, Diabetes Care, and Ophthalmic Epidemiology; and receives research support from the National Medical Research Council of Singapore and the Singapore Biomedical Research. Dr. M.-C. Wong receives research support from the National Medical Research Council (NMRC) of Singapore.